Paper7943392
NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action.
Schlüter KD and 3 others. Am J Physiol, 1994. Cited by 20 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action. Papers, record 7943392. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7943392
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Heart | Major topic |
| Molsidomine | Major topic |
| Myocardial Contraction | Major topic |
| Nitric Oxide | Major topic |
| Adenosine Diphosphate | |
| Animals | |
| Cell Hypoxia | |
| Cells, Cultured | |
| Dose-Response Relationship, Drug | |
| Electric Stimulation | |
| Heart Ventricles | |
| Kinetics | |
| Male | |
| Methylene Blue | |
| Myocardium | |
| Nitroprusside | |
| Oxygen | |
| Rats | |
| Rats, Wistar | |
| Thermodynamics | |
| Time Factors |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18773197 | The metalloporphyrin FeTPPS but not by cyclosporin A antagonizes the interaction of peroxynitrate and hydrogen peroxide on cardiomyocyte cell death. | Naunyn Schmiedebergs Arch Pharmacol | 2009 | https://conductscience.org/library/papers/18773197 | PubMed |
| 14586658 | Mechanism of the positive contractile effect of nitric oxide on rat ventricular cardiomyocytes with positive force/frequency relationship. | Pflugers Arch | 2003 | https://conductscience.org/library/papers/14586658 | PubMed |
| 12379822 | Myocardial contractile effects of nitric oxide. | Heart Fail Rev | 2002 | https://conductscience.org/library/papers/12379822 | PubMed |
| 11890646 | Novel targets for interleukin 18 binding protein. | Ann Rheum Dis | 2001 | https://conductscience.org/library/papers/11890646 | PubMed |
| 11226333 | Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11226333 | PubMed |
| 10639218 | Reperfusion Injury: Basic Concepts and Protection Strategies. | J Thromb Thrombolysis | 1997 | https://conductscience.org/library/papers/10639218 | PubMed |
| 7582534 | Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/7582534 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7943392
GET https://conductscience.org/api/papers/v1/7943392/authors